| Future Health Pharma GmbH - abnobaVISCUM Fraxini D30, anthroposophisches Arzneimittel |
| 68315 | | 08 | | abnobaVISCUM Fraxini D30 | | anthroposophisches Arzneimittel | | L01CX | | Other Plant Alkaloids and Natural Products | | 28.10.2022 | | |
|
| Composition |
| viscum album fraxini ex herba recente col. D30 (HAB 32) 1 ml, natrii chloridum, aqua ad iniectabile, pro vitro 1 ml corresp. natrium 3.5 mg. |
| Packungsbestandteile |
| anthroposophisches Arzneimittel | | | | | | Active Agent | Dose |
|---|
| Viscum Album Fraxini ex Herba Recente col. D30 (Hab 32) | 1 ml |
| | | | Inactive agents |
|---|
| Sodium Chloride |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 016 | 8 x 1 ml | PR | PR | A | | Yes |
|
